GB2176999B - Sustained release medicament - Google Patents

Sustained release medicament

Info

Publication number
GB2176999B
GB2176999B GB8515851A GB8515851A GB2176999B GB 2176999 B GB2176999 B GB 2176999B GB 8515851 A GB8515851 A GB 8515851A GB 8515851 A GB8515851 A GB 8515851A GB 2176999 B GB2176999 B GB 2176999B
Authority
GB
United Kingdom
Prior art keywords
sustained release
release medicament
medicament
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8515851A
Other versions
GB2176999A (en
GB8515851D0 (en
Inventor
Stanley Stewart Davis
Liam Feely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8515851A priority Critical patent/GB2176999B/en
Publication of GB8515851D0 publication Critical patent/GB8515851D0/en
Publication of GB2176999A publication Critical patent/GB2176999A/en
Application granted granted Critical
Publication of GB2176999B publication Critical patent/GB2176999B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
GB8515851A 1985-06-22 1985-06-22 Sustained release medicament Expired GB2176999B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8515851A GB2176999B (en) 1985-06-22 1985-06-22 Sustained release medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8515851A GB2176999B (en) 1985-06-22 1985-06-22 Sustained release medicament

Publications (3)

Publication Number Publication Date
GB8515851D0 GB8515851D0 (en) 1985-07-24
GB2176999A GB2176999A (en) 1987-01-14
GB2176999B true GB2176999B (en) 1989-07-12

Family

ID=10581190

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8515851A Expired GB2176999B (en) 1985-06-22 1985-06-22 Sustained release medicament

Country Status (1)

Country Link
GB (1) GB2176999B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IT1243341B (en) * 1990-07-13 1994-06-10 Farcon Ag PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS
IT1250483B (en) * 1990-08-30 1995-04-07 Eurand Int MULTIPLE DIE DELAY SYSTEM
IL109097A0 (en) * 1993-04-03 1994-06-24 Knoll Ag Delayed release micro tablet of beta-phenylpropiophenone derivatives and its production
ATE181672T1 (en) * 1993-04-28 1999-07-15 Takeda Chemical Industries Ltd FLAVOR-MASKED SOLID PREPARATION AND METHOD FOR PRODUCING
DE19853487A1 (en) 1998-11-19 2000-05-25 Fumapharm Ag Muri Use of dialkyl fumarate for treating transplant rejection and autoimmune disease
EP1204406A2 (en) * 1999-07-29 2002-05-15 Roxane Laboratories, Inc. Opioid sustained-released formulation
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
MXPA06002657A (en) 2003-09-09 2006-06-05 Fumapharm Ag The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma.
EP2890366A1 (en) 2012-08-28 2015-07-08 DSM Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at least one of them is in the form of mini-tablets

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098867A (en) * 1981-05-21 1982-12-01 Wyeth John & Brother Ltd Sustained release pharmaceutical composition
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
EP0164967A2 (en) * 1984-06-04 1985-12-18 Sterwin Ag. Pharmaceutical composition of sparingly soluble medicament and method for its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098867A (en) * 1981-05-21 1982-12-01 Wyeth John & Brother Ltd Sustained release pharmaceutical composition
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
EP0156592A2 (en) * 1984-03-21 1985-10-02 American Home Products Corporation Substained release pharmaceutical capsules
EP0164967A2 (en) * 1984-06-04 1985-12-18 Sterwin Ag. Pharmaceutical composition of sparingly soluble medicament and method for its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations

Also Published As

Publication number Publication date
GB2176999A (en) 1987-01-14
GB8515851D0 (en) 1985-07-24

Similar Documents

Publication Publication Date Title
EP0187703A3 (en) Sustained release preparation
ZA868039B (en) Sustained release tablets
ZA866861B (en) New drug preparation
ZA88941B (en) Sustained release dosage forms
PT80366A (en) Drug release device
GB8607817D0 (en) Drug preparation
GB2176999B (en) Sustained release medicament
GB8629568D0 (en) Therapeutic agent
GB8430703D0 (en) Drug release devices
EP0305902A3 (en) Medicament
GB8620716D0 (en) Medicament
GB8529885D0 (en) Therapeutic agent
ZA853109B (en) Drug release device
GB8623087D0 (en) Release unit
GB8511255D0 (en) Medicament preparation
IE851058L (en) Drug release device
PH21756A (en) Drug release device
IE850698L (en) Sustained release pharmaceutical capsule
GB8705553D0 (en) Medicament
IE872675L (en) Sustained release pharmaceutical
GB8529079D0 (en) Pharmaceutical agents
IE851357L (en) Sustained release composition
GB8707175D0 (en) Medicaments
GB8707176D0 (en) Medicaments
GB8726424D0 (en) Medicaments

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19990622